Semax and Selank are synthetic regulatory peptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Both are based on naturally occurring peptide fragments modified for enhanced stability and activity.
Semax: ACTH Fragment
Semax is a heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) based on the 4–10 fragment of adrenocorticotropic hormone (ACTH). The C-terminal Pro-Gly-Pro extension confers resistance to enzymatic degradation while maintaining BDNF-upregulating activity and melanocortin receptor modulation.
Selank: Tuftsin Analog
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is based on the immunomodulatory tetrapeptide tuftsin, also with a Pro-Gly-Pro stabilizing extension. It modulates the expression of IL-6, BDNF, and enkephalin genes, with research focusing on its anxiolytic and nootropic properties.
Intranasal Administration
Both peptides are typically studied via intranasal administration in preclinical models, taking advantage of the nasal mucosa’s direct access to the CNS via olfactory and trigeminal pathways.